Standards; Pharmaceutical/API Drug Impurities/Metabolites;
Treosulfan is used as myeloablative agent in conditioning regimen prior to allogeneic hematopoietic stem cell transplantation (HSCT). It can also be an effective agent for conditioning children with inborn errors of immunity (IEI).